Weston P F, Overstreet D H
Pharmacol Biochem Behav. 1976 Dec;5(6):645-9. doi: 10.1016/0091-3057(76)90306-3.
An observational study of the behavioural effects of chronic regimens of d- and l-amphetamine was designed to investigate possible mechanisms underlying any parallel behavioural changes: (1) Accumulation of p-hydroxynorephedrine in noradrenergic nerve terminals; (2) Altered sensitivity of dopaminergic receptors. The study revealed that locomotor activity seen with low doses of both isomers (2.0 mg/kg d- and 6.0 mg/kg l-) decreased with chronic once daily treatment. However, this was accompanied by an increase in directed sniffing activity and the behaviour came to resemble that seen with higher doses of amphetamine (8.0 mg/kg d- and 16.0 mg/kg l-). Nonsignificant decreases in locomotor activity and increases in directed sniffing to apomorphine administration were observed during chronic amphetamine treatment. These findings suggest that (1) p-hydroxynorephedrine, a metabolite of d- but not 1- amphetamine, does not play an important role in these alterations in behaviour with chronic treatment and (2) the tolerance to amphetamine observed under these conditions is due to an increased, rather than decreased, sensitivity of the rats to amphetamine.
一项关于 d-和 l-苯丙胺慢性给药行为效应的观察性研究旨在探究任何平行行为变化背后的潜在机制:(1)对羟基去甲麻黄碱在去甲肾上腺素能神经末梢的积累;(2)多巴胺能受体敏感性的改变。该研究表明,两种异构体低剂量(2.0 mg/kg d-和 6.0 mg/kg l-)时出现的运动活性在每日一次的慢性治疗后降低。然而,这伴随着定向嗅探活动的增加,且行为变得类似于高剂量苯丙胺(8.0 mg/kg d-和 16.0 mg/kg l-)时所见的行为。在慢性苯丙胺治疗期间,观察到给予阿扑吗啡后运动活性有不显著的降低以及定向嗅探有增加。这些发现表明:(1)对羟基去甲麻黄碱,一种 d-苯丙胺而非 l-苯丙胺的代谢产物,在慢性治疗后的这些行为改变中不起重要作用;(2)在这些条件下观察到的对苯丙胺的耐受性是由于大鼠对苯丙胺的敏感性增加而非降低。